Futura Medical plc

Futura Medical plc operates as a pharmaceutical firm specializing in the creation and advancement of consumer healthcare products. The company primarily targets the sexual health and pain management sectors. Its leading innovation is MED3000, a topical gel specifically formulated to treat erectile dysfunction. Additionally, Futura Medical offers a variety of pain relief solutions, including TPR100, a topical diclofenac gel; CBD100, a cannabidiol-based topical application; and TIB200, an ibuprofen topical gel. Established in 2001, the company is headquartered in Guildford, United Kingdom.